Verona Pharma segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Verona Pharma utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
VRNA | Verona Pharma | -$0.53 | $0.26 | — | — | $5.62M | $120.19M | — | — | 11/03/2025 | |
VRNA | Verona Pharma | -$0.80 | $0.02 | $0.13 | 116.67% | $0.00 | $92.14M | $103.14M | 33.48% | 08/06/2025 | |
VRNA | Verona Pharma | -$0.32 | -$0.14 | -$0.16 | 27.27% | $0.00 | $52.71M | $76.26M | 56.49% | 04/29/2025 | |
VRNA | Verona Pharma | -$0.18 | -$0.29 | -$0.40 | -73.91% | $0.00 | $33.05M | $36.66M | 1.57% | 02/27/2025 | |
VRNA | Verona Pharma | -$0.16 | -$0.45 | -$0.53 | -6.00% | $0.00 | $5.78M | $5.62M | 179.80% | 11/04/2024 | |
VRNA | Verona Pharma | -$0.11 | -$0.37 | -$0.80 | -175.86% | $0.00 | $1.53M | $0.00 | — | 08/08/2024 | |
VRNA | Verona Pharma | -$0.22 | -$0.16 | -$0.32 | -100.00% | $0.00 | — | $0.00 | — | 05/09/2024 | |
VRNA | Verona Pharma | -$0.14 | -$0.26 | -$0.18 | 30.77% | $458.00K | $0.00 | $0.00 | — | 02/29/2024 | |
VRNA | Verona Pharma | -$0.23 | -$0.28 | -$0.16 | 42.86% | $0.00 | — | $0.00 | — | 11/02/2023 | |
VRNA | Verona Pharma | -$0.32 | -$0.27 | -$0.11 | 59.26% | $0.00 | — | $0.00 | — | 08/03/2023 | |
VRNA | Verona Pharma | -$0.40 | -$0.19 | -$0.22 | -15.79% | $0.00 | — | $0.00 | — | 05/09/2023 | |
VRNA | Verona Pharma | -$0.40 | -$0.10 | -$0.14 | -40.00% | $0.00 | $3.57M | $458.00K | -87.17% | 03/07/2023 | |
VRNA | Verona Pharma | $0.16 | -$0.16 | -$0.23 | -43.75% | $40.00M | $3.57M | $0.00 | -100.00% | 11/09/2022 | |
VRNA | Verona Pharma | -$0.40 | -$0.38 | -$0.32 | 15.79% | $0.00 | — | $0.00 | — | 08/09/2022 | |
VRNA | Verona Pharma | -$0.40 | -$0.47 | -$0.40 | 14.89% | $0.00 | — | $0.00 | — | 05/03/2022 | |
VRNA | Verona Pharma | -$0.40 | -$0.48 | -$0.40 | 16.67% | $0.00 | — | $0.00 | — | 03/03/2022 | |
VRNA | Verona Pharma | -$0.46 | -$0.37 | $0.16 | 143.24% | $0.00 | $4.17M | $40.00M | 859.23% | 11/09/2021 | |
VRNA | Verona Pharma | -$0.72 | -$0.44 | -$0.40 | 9.09% | $0.00 | — | $0.00 | — | 08/05/2021 | |
VRNA | Verona Pharma | -$0.96 | -$0.47 | -$0.40 | 14.89% | $0.00 | — | $0.00 | — | 04/29/2021 | |
VRNA | Verona Pharma | -$0.72 | -$0.35 | -$0.40 | -14.29% | $0.00 | — | $0.00 | — | 02/25/2021 | |
VRNA | Verona Pharma | -$0.96 | -$0.22 | -$0.46 | -109.09% | $0.00 | — | $0.00 | — | 10/29/2020 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-06 | $0.13 | $0.02 | 116.7 % |
Q1 | 2025-04-29 | $-0.16 | $-0.14 | 27.3 % |
Q4 | 2025-02-27 | $-0.40 | $-0.29 | -73.9 % |
Q3 | 2024-11-04 | $-0.53 | $-0.45 | -6.00 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-06 | $103.14M | $92.14M | 33.5 % |
Q1 | 2025-04-29 | $76.26M | $52.71M | 56.5 % |
Q4 | 2025-02-27 | $36.66M | $33.05M | 1.57 % |
Q3 | 2024-11-04 | $5.62M | $5.78M | 179.8 % |
Si prevede che Verona Pharma (VRNA) fornisca risultati il novembre 3, 2025. Gli ultimi risultati sono stati pubblicati il agosto 6, 2025 per il Q2.
L'EPS effettivo era $0.13, che superato la stima di $0.02.
Le entrate effettive sono state $103.1M, che superato la stima di $92.1M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.